Myriad Genetics, Intermountain Health Care deal

The parties agreed to identify genes involved in diseases of the central nervous system. The program will link anonymous patient records from Intermountain Health’s hospital database to MYGN’s genealogy database for disorders of the CNS. MYGN has exclusive rights to all diagnostic and therapeutic applications resulting from the research. ...